News Psychedelics and mental health: The time is now? Following news this week of Australia becoming the first country to legalise the prescription of the psychedelics MDMA for PTSD and
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.
